NNC0640

NNC0640 Suppliers list
Company Name: ATK CHEMICAL COMPANY LIMITED
Tel: +undefined-21-51877795
Email: ivan@atkchemical.com
Products Intro: Product Name:NNC0640
CAS:307986-98-7
Purity:98% Package:10MG;50MG;100MG,1G,5G,10G.100G
Company Name: InvivoChem
Tel: +1-708-310-1919 +1-13798911105
Email: sales@invivochem.cn
Products Intro: Product Name:NNC0640
CAS:307986-98-7
Purity:98% Package:5mg Remarks:V22035
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354
Email: support@targetmol.com
Products Intro: Product Name:NNC-0640
CAS:307986-98-7
Package:10 mg;2 mg;5 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Shenyang Zhongshen Zekang Biomedical Technology Research Co., Ltd
Tel: +86-18341751992 +86-15382112998
Email: 757984502@qq.com
Products Intro: Product Name:NNC0640
CAS:307986-98-7
Purity:98 Package:500mg;1g;5g;10g;25g Remarks:Provide customized services
Company Name: Aladdin Scientific
Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Products Intro: Product Name:NNC 0640
CAS:307986-98-7
Purity:>=97%(HPLC) Package:$206.9/10mg;$573.9/50mg;$870.9/100mg;Bulk package Remarks:97%(HPLC)
NNC0640 Basic information
Product Name:NNC0640
Synonyms:NNC0640;Benzamide, 4-[[(4-cyclohexylphenyl)[[[3-(methylsulfonyl)phenyl]amino]carbonyl]amino]methyl]-N-2H-tetrazol-5-yl-;NNC-0640,Glucagon Receptor,NNC0640,GCGR,inhibit,Inhibitor,NNC 0640;4-((1-(4-Cyclohexylphenyl)-3-(3-(methylsulfonyl)phenyl)ureido)methyl)-N-(1H-tetrazol-5-yl)benzamide
CAS:307986-98-7
MF:C29H31N7O4S
MW:573.67
EINECS:
Product Categories:
Mol File:307986-98-7.mol
NNC0640 Structure
NNC0640 Chemical Properties
storage temp. Store at -20°C
solubility DMSO:57.37(Max Conc. mg/mL);100.0(Max Conc. mM)
form Solid
color White to off-white
Safety Information
MSDS Information
NNC0640 Usage And Synthesis
DescriptionNNC0640 is a negative allosteric modulator of glucagon-like peptide-1 receptor (GLP-1R).
in vitroCrystal structures of the human GLP-1R transmembrane domain in complex with two different negative allosteric modulators, PF-06372222 and NNC0640, at 2.7 and 3.0 ? resolution, respectively were reported. The structures reveal a common binding pocket for negative allosteric modulators, present in both GLP-1R and GCGR and located outside helices V-VII near the intracellular half of the receptor. The receptor is in an inactive conformation with compounds that restrict movement of the intracellular tip of helix VI, a movement that is generally associated with activation mechanisms in class A GPCRs. Molecular modelling and mutagenesis studies indicate that agonist positive allosteric modulators target the same general region, but in a distinct sub-pocket at the interface between helices V and VI, which may facilitate the formation of an intracellular binding site that enhances G-protein coupling._x000D_ _x000D_ Reference: Song G, Yang D, Wang Y, de Graaf C, Zhou Q, Jiang S, Liu K, Cai X, Dai A, Lin G, Liu D, Wu F, Wu Y, Zhao S, Ye L, Han GW, Lau J, Wu B, Hanson MA, Liu ZJ, Wang MW, Stevens RC. Human GLP-1 receptor transmembrane domain structure in complex with allosteric modulators. Nature. 2017 Jun 8;546(7657):312-315. doi: 10.1038/nature22378. Epub 2017 May 17. PMID: 28514449.
targetGlucagon receptors (pKi = 7.4).
storageStore at -20°C
NNC0640 Preparation Products And Raw materials
Tag:NNC0640(307986-98-7) Related Product Information